Product Code: ETC13146442 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Hereditary Angioedema Treatment Market was valued at USD 2.4 Billion in 2024 and is expected to reach USD 3.3 Billion by 2031, growing at a compound annual growth rate of 4.70% during the forecast period (2025-2031).
The Global Hereditary Angioedema Treatment Market is witnessing steady growth driven by advancements in treatment options, increasing awareness about the condition, and rising prevalence of hereditary angioedema worldwide. Key players in the market are focusing on developing innovative therapies such as C1 esterase inhibitors, bradykinin receptor antagonists, and kallikrein inhibitors to effectively manage and treat hereditary angioedema. The market is also benefiting from strategic collaborations, mergers, and acquisitions among pharmaceutical companies to expand their product portfolios and reach a broader patient population. North America dominates the market due to the high prevalence of hereditary angioedema in the region, followed by Europe and Asia Pacific. With ongoing research and development activities, the Global Hereditary Angioedema Treatment Market is expected to grow further in the coming years.
The Global Hereditary Angioedema (HAE) Treatment Market is witnessing significant growth due to an increased awareness about the disease, advancements in treatment options, and rising investments in research and development. The market is experiencing a shift towards novel therapies such as monoclonal antibodies and gene therapy, offering more targeted and effective treatment options for patients. Additionally, the expanding patient pool, particularly in emerging markets, presents lucrative opportunities for market players to expand their presence and tap into new revenue streams. Collaborations and partnerships between pharmaceutical companies and research institutions are also on the rise, fostering innovation and the development of breakthrough therapies. Overall, the Global HAE Treatment Market is poised for continued growth and innovation in the coming years.
The Global Hereditary Angioedema Treatment Market faces several challenges, including limited awareness about the disease among both patients and healthcare providers, leading to underdiagnosis and delayed treatment initiation. Additionally, the high cost of treatment options, such as long-term prophylactic therapies and acute attack medications, can create financial barriers for patients, especially in regions with limited access to healthcare resources. Another challenge is the complexity of managing hereditary angioedema, as the condition requires personalized treatment plans tailored to each patient`s specific needs, which can be challenging to implement effectively. Furthermore, ongoing research is needed to develop more accessible and affordable treatment options to improve outcomes and quality of life for individuals living with hereditary angioedema.
The Global Hereditary Angioedema Treatment Market is primarily driven by the increasing prevalence of hereditary angioedema (HAE) worldwide, leading to a growing demand for effective treatment options. Technological advancements in drug development and the approval of novel therapies, such as monoclonal antibodies and gene therapy, are also driving market growth. Additionally, rising awareness about HAE among healthcare professionals and patients, coupled with improving healthcare infrastructure in emerging economies, are further contributing to the expansion of the market. The availability of reimbursement for HAE treatments in developed markets and the emphasis on early diagnosis and treatment are expected to propel the market in the forecast period.
Government policies related to the Global Hereditary Angioedema Treatment Market vary across different regions. In the United States, the FDA has approved various drugs for the treatment of hereditary angioedema, such as C1 esterase inhibitors and bradykinin receptor antagonists. These approvals have facilitated market growth by providing patients with access to effective treatments. In Europe, regulatory bodies like the European Medicines Agency (EMA) also play a key role in approving and regulating drugs for hereditary angioedema. Additionally, government healthcare systems in countries like the UK and Germany may influence market dynamics through pricing and reimbursement policies. Overall, government policies play a crucial role in shaping the landscape of the Global Hereditary Angioedema Treatment Market by influencing drug approvals, access, and affordability for patients.
The Global Hereditary Angioedema Treatment Market is poised for significant growth in the coming years, driven by factors such as increasing awareness about the disease, advancements in treatment options, and rising prevalence of hereditary angioedema worldwide. The market is expected to witness a steady rise in demand for innovative therapies, including prophylactic and on-demand medications, as well as gene therapy approaches. Moreover, collaborations between pharmaceutical companies and research institutions for the development of novel treatment solutions are likely to propel market expansion. With a growing emphasis on personalized medicine and precision therapies, the hereditary angioedema treatment market is anticipated to experience substantial investment and research activities, leading to improved patient outcomes and a broader range of therapeutic options in the future.
The global hereditary angioedema treatment market shows variations across regions. In North America, the market is well-established with extensive research and development activities, leading to the availability of advanced treatment options. Europe also boasts a significant market share, driven by increasing awareness and government initiatives promoting early diagnosis and treatment. Asia Pacific is witnessing rapid growth due to improving healthcare infrastructure and rising prevalence of hereditary angioedema. In the Middle East and Africa region, the market is expanding gradually with growing investment in healthcare and increasing focus on rare diseases. Latin America is experiencing steady growth, supported by rising healthcare expenditure and efforts to enhance access to treatment options. Overall, the global hereditary angioedema treatment market is expected to continue evolving across these regions with varying pace and dynamics.
Global Hereditary Angioedema Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Hereditary Angioedema Treatment Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Hereditary Angioedema Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Global Hereditary Angioedema Treatment Market - Industry Life Cycle |
3.4 Global Hereditary Angioedema Treatment Market - Porter's Five Forces |
3.5 Global Hereditary Angioedema Treatment Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Hereditary Angioedema Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Global Hereditary Angioedema Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Hereditary Angioedema Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Hereditary Angioedema Treatment Market Trends |
6 Global Hereditary Angioedema Treatment Market, 2021 - 2031 |
6.1 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.1.3 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Subcutaneous Injection, 2021 - 2031 |
6.1.4 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.2.3 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.2.4 Global Hereditary Angioedema Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Hereditary Angioedema Treatment Market, Overview & Analysis |
7.1 North America Hereditary Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
7.2 North America Hereditary Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4 North America Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Hereditary Angioedema Treatment Market, Overview & Analysis |
8.1 Latin America (LATAM) Hereditary Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Hereditary Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.4 Latin America (LATAM) Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Hereditary Angioedema Treatment Market, Overview & Analysis |
9.1 Asia Hereditary Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Hereditary Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.4 Asia Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Hereditary Angioedema Treatment Market, Overview & Analysis |
10.1 Africa Hereditary Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Hereditary Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.4 Africa Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Hereditary Angioedema Treatment Market, Overview & Analysis |
11.1 Europe Hereditary Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Hereditary Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.4 Europe Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Hereditary Angioedema Treatment Market, Overview & Analysis |
12.1 Middle East Hereditary Angioedema Treatment Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Hereditary Angioedema Treatment Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Hereditary Angioedema Treatment Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Hereditary Angioedema Treatment Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.4 Middle East Hereditary Angioedema Treatment Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Hereditary Angioedema Treatment Market Key Performance Indicators |
14 Global Hereditary Angioedema Treatment Market - Export/Import By Countries Assessment |
15 Global Hereditary Angioedema Treatment Market - Opportunity Assessment |
15.1 Global Hereditary Angioedema Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Hereditary Angioedema Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.3 Global Hereditary Angioedema Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Hereditary Angioedema Treatment Market - Competitive Landscape |
16.1 Global Hereditary Angioedema Treatment Market Revenue Share, By Companies, 2024 |
16.2 Global Hereditary Angioedema Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |